Assessing Whether Altimmune Inc (NASDAQ: ALT) Is Over- Or Undervalued
Altimmune Inc (ALT) concluded trading on Wednesday at a closing price of $8.05, with 4.74 million shares of worth about $38.19 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 2.03% during that period and on November 20, 2024 the price saw a gain […]
Tomorrow Is Not Likely To Be Same For Altimmune Inc (ALT)
Altimmune Inc (ALT) concluded trading on Thursday at a closing price of $7.46, with 4.23 million shares of worth about $31.52 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -3.37% during that period and on November 07, 2024 the price saw a gain […]
Gains May Be On The Menu For Altimmune Inc (NASDAQ: ALT)
Currently, there are 53.73M common shares owned by the public and among those 53.08M shares have been available to trade. Insiders at the company have transacted a total of 9 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 9 of these insider trades were purchases, […]
Altimmune Inc (NASDAQ: ALT) – Suitable For Long Term Buy?
Currently, there are 53.73M common shares owned by the public and among those 53.12M shares have been available to trade. Insiders at the company have transacted a total of 9 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 9 of these insider trades were purchases, […]
Analyst Expect Big Moves From Altimmune Inc (NASDAQ: ALT)
BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $38.71 million. In addition, The Vanguard Group, […]
Reassessing The Changing Outlook For Altimmune Inc (ALT)
BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $38.71 million. In addition, The Vanguard Group, […]
Altimmune Inc (NASDAQ: ALT) Is Getting Increasingly Hard To Ignore
With over 10.36 million Altimmune Inc (ALT) shares trading Friday and a closing price of $11.19 on the day, the dollar volume was approximately $115.9 million. The shares have shown a positive half year performance of 240.12% and its price on 01/05/24 lost nearly -4.28%. Currently, there are 53.73M common shares owned by the public […]
Uncovering Institutional Buying In Altimmune Inc (NASDAQ: ALT)
BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $10.87 million. In addition, The Vanguard Group, […]
Altimmune Inc (NASDAQ: ALT): The Best-Of-Breed For Investing?
BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $10.87 million. In addition, The Vanguard Group, […]
